Literature DB >> 21187447

CR2+ marginal zone B cell production of pathogenic natural antibodies is C3 independent.

Keith M Woods1, Michael R Pope, Sara M Hoffman, Sherry D Fleming.   

Abstract

Intestinal ischemia-reperfusion (IR)-induced damage requires complement receptor 2 (CR2) for generation of the appropriate natural Ab repertoire. Pathogenic Abs recognize neoantigens on the ischemic tissue, activate complement, and induce intestinal damage. Because C3 cleavage products act as ligands for CR2, we hypothesized that CR2(hi) marginal zone B cells (MZBs) require C3 for generation of the pathogenic Abs. To explore the ability of splenic CR2(+) B cells to generate the damaging Ab repertoire, we adoptively transferred either MZBs or follicular B cells (FOBs) from C57BL/6 or Cr2(-/-) mice into Rag-1(-/-) mice. Adoptive transfer of wild type CR2(hi) MZBs but not CR2(lo) FOBs induced significant damage, C3 deposition, and inflammation in response to IR. In contrast, similarly treated Rag-1(-/-) mice reconstituted with either Cr2(-/-) MZB/B1 B cells (B1Bs) or FOBs lacked significant intestinal damage and displayed limited complement activation. To determine whether C3 cleavage products are critical in CR2-dependent Ab production, we evaluated the ability of the natural Ab repertoire of C3(-/-) mice to induce damage in response to IR. Infusion of C3(-/-) serum into Cr2(-/-) mice restored IR-induced tissue damage. Furthermore, Rag-1(-/-) mice sustained significant damage after infusion of Abs from C3(-/-) but not Cr2(-/-) mice. Finally, adoptive transfer of MZBs from C3(-/-) mice into Rag-1(-/-) mice resulted in significant tissue damage and inflammation. These data indicate that CR2 expression on MZBs is sufficient to induce the appropriate Abs required for IR-induced tissue damage and that C3 is not critical for generation of the pathogenic Abs.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21187447      PMCID: PMC3024465          DOI: 10.4049/jimmunol.1002059

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  53 in total

Review 1.  Inherent specificities in natural antibodies: a key to immune defense against pathogen invasion.

Authors:  Nicole Baumgarth; James W Tung; Leonore A Herzenberg
Journal:  Springer Semin Immunopathol       Date:  2005-01-05

Review 2.  Marginal zone B cells.

Authors:  Shiv Pillai; Annaiah Cariappa; Stewart T Moran
Journal:  Annu Rev Immunol       Date:  2005       Impact factor: 28.527

Review 3.  Natural antibody mediated innate autoimmune response.

Authors:  Ming Zhang; Michael C Carroll
Journal:  Mol Immunol       Date:  2006-07-28       Impact factor: 4.407

Review 4.  Complement receptor 2, natural antibodies and innate immunity: Inter-relationships in B cell selection and activation.

Authors:  V Michael Holers; Liudmila Kulik
Journal:  Mol Immunol       Date:  2006-07-28       Impact factor: 4.407

Review 5.  Complement mediators in ischemia-reperfusion injury.

Authors:  Thiruma V Arumugam; Tim Magnus; Trent M Woodruff; Lavinia M Proctor; Ian A Shiels; Stephen M Taylor
Journal:  Clin Chim Acta       Date:  2006-06-14       Impact factor: 3.786

Review 6.  Natural antibodies, autoantibodies and complement activation in tissue injury.

Authors:  Sherry D Fleming
Journal:  Autoimmunity       Date:  2006-08       Impact factor: 2.815

7.  Mannose-binding lectin is a regulator of inflammation that accompanies myocardial ischemia and reperfusion injury.

Authors:  Mary C Walsh; Todd Bourcier; Kazue Takahashi; Lei Shi; Marc N Busche; Russell P Rother; Scott D Solomon; R Alan B Ezekowitz; Gregory L Stahl
Journal:  J Immunol       Date:  2005-07-01       Impact factor: 5.422

8.  Antibody-independent B cell-intrinsic and -extrinsic roles for CD21/35.

Authors:  Joerg Rossbacher; Ann M Haberman; Susanne Neschen; Ashraf Khalil; Mark J Shlomchik
Journal:  Eur J Immunol       Date:  2006-09       Impact factor: 5.532

9.  Characterization of human complement receptor type 2 (CR2/CD21) as a receptor for IFN-alpha: a potential role in systemic lupus erythematosus.

Authors:  Rengasamy Asokan; Jing Hua; Kendra A Young; Hannah J Gould; Jonathan P Hannan; Damian M Kraus; Gerda Szakonyi; Gabrielle J Grundy; Xiaojiang S Chen; Mary K Crow; V Michael Holers
Journal:  J Immunol       Date:  2006-07-01       Impact factor: 5.422

10.  Identification of the target self-antigens in reperfusion injury.

Authors:  Ming Zhang; Elisabeth M Alicot; Isaac Chiu; Jinan Li; Nicola Verna; Thomas Vorup-Jensen; Benedikt Kessler; Motomu Shimaoka; Rodney Chan; Daniel Friend; Umar Mahmood; Ralph Weissleder; Francis D Moore; Michael C Carroll
Journal:  J Exp Med       Date:  2006-01-03       Impact factor: 14.307

View more
  2 in total

1.  Central role for marginal zone B cells in an animal model of Sjogren's syndrome.

Authors:  Long Shen; Chun Gao; Lakshmanan Suresh; Zhenhua Xian; Nannan Song; Lee D Chaves; Meixing Yu; Julian L Ambrus
Journal:  Clin Immunol       Date:  2016-04-30       Impact factor: 3.969

2.  The soluble pattern recognition receptor PTX3 links humoral innate and adaptive immune responses by helping marginal zone B cells.

Authors:  Alejo Chorny; Sandra Casas-Recasens; Jordi Sintes; Meimei Shan; Nadia Polentarutti; Ramón García-Escudero; A Cooper Walland; John R Yeiser; Linda Cassis; Jorge Carrillo; Irene Puga; Cristina Cunha; Hélder Bastos; Fernando Rodrigues; João F Lacerda; António Morais; Rebeca Dieguez-Gonzalez; Peter S Heeger; Giovanni Salvatori; Agostinho Carvalho; Adolfo Garcia-Sastre; J Magarian Blander; Alberto Mantovani; Cecilia Garlanda; Andrea Cerutti
Journal:  J Exp Med       Date:  2016-09-12       Impact factor: 17.579

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.